Economic evaluation of the chronic hepatitis B treatment strategies in Italy

BACKGROUND AND OBJECTIVE: Pharmacological approaches available in chronic hepatitis B (CHB) are based on 48-weeks finite course of peg-interferon (PEG-IFN) or continuous administration of nucleoside analogues. Recent studies gave way to early identification of non-responders to peg-interferon with a...

Full description

Bibliographic Details
Main Authors: Sergio Iannazzo, Barbara Coco, Maurizia Brunetto, Francesca Rossetti, Antonietta Caputo, Maria De Francesco, Ferruccio Bonino
Format: Article
Language:English
Published: SEEd Medical Publishers 2013-09-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/665